project id: TCGA-STAD; case submitter id: TCGA-IN-A7NR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 7.3; age at index: 64; days to birth: -23415; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23415; ajcc pathologic m: M1; ajcc pathologic n: N3; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 198.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 233; initial weight: 220.0; sample id: 19af171a-cc13-4110-ba75-6f0fffedfcc7; sample submitter id: TCGA-IN-A7NR-01A; portion id: c197c671-7daf-4552-81ca-32c05dc07ff6; portion submitter id: TCGA-IN-A7NR-01A-11; slide id: 78573e4e-1a66-409a-ab9d-7bd1262cf596; slide submitter id: TCGA-IN-A7NR-01A-01-TSA; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 25.0; percent stromal cells: 0.0; percent tumor cells: 75.0; percent tumor nuclei: 60.0; section location: TOP;